Trial Outcomes & Findings for Motivation, Syringe Exchange, and COVID-19 (NCT NCT05534061)
NCT ID: NCT05534061
Last Updated: 2024-02-28
Results Overview
Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was tested for SARS-CoV-2 testing at syringe exchange visit, data collected from medical record
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
349 participants
Primary outcome timeframe
Immediate post intervention (i.e., same day)
Results posted on
2024-02-28
Participant Flow
Participant milestones
| Measure |
Connect2Test Intervention + Contingency Management
$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
Contingency Management Alone
$10 financial incentive for vaccination and $10 financial incentive for testing.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
|---|---|---|
|
Overall Study
STARTED
|
177
|
172
|
|
Overall Study
COMPLETED
|
177
|
172
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Motivation, Syringe Exchange, and COVID-19
Baseline characteristics by cohort
| Measure |
Connect2Test Intervention + Contingency Management
n=177 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
Contingency Management Alone
n=172 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
Total
n=349 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
42.60 years
STANDARD_DEVIATION 11.23 • n=5 Participants
|
45.19 years
STANDARD_DEVIATION 10.80 • n=7 Participants
|
43.92 years
STANDARD_DEVIATION 11.11 • n=5 Participants
|
|
Sex/Gender, Customized
Female
|
53 Participants
n=5 Participants
|
51 Participants
n=7 Participants
|
104 Participants
n=5 Participants
|
|
Sex/Gender, Customized
Male
|
89 Participants
n=5 Participants
|
88 Participants
n=7 Participants
|
177 Participants
n=5 Participants
|
|
Sex/Gender, Customized
Non-binary
|
2 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
|
Sex/Gender, Customized
Bigender
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Sex/Gender, Customized
None of the listed categories
|
2 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Sex/Gender, Customized
Unknown or not reported
|
31 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
56 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
6 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
14 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
4 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
109 Participants
n=5 Participants
|
113 Participants
n=7 Participants
|
222 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
8 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
19 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
50 Participants
n=5 Participants
|
31 Participants
n=7 Participants
|
81 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
13 Participants
n=5 Participants
|
14 Participants
n=7 Participants
|
27 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Non-Hispanic
|
92 Participants
n=5 Participants
|
88 Participants
n=7 Participants
|
180 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Unknown or Not Reported
|
72 Participants
n=5 Participants
|
70 Participants
n=7 Participants
|
142 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Immediate post intervention (i.e., same day)Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was tested for SARS-CoV-2 testing at syringe exchange visit, data collected from medical record
Outcome measures
| Measure |
Connect2Test Intervention + Contingency Management
n=177 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
Contingency Management Alone
n=172 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
|---|---|---|
|
SARS-CoV-2 Testing
Was tested
|
54 Participants
|
53 Participants
|
|
SARS-CoV-2 Testing
Was not tested
|
123 Participants
|
119 Participants
|
PRIMARY outcome
Timeframe: Up to 9-months after interventionYes/no indicator (coded 1 = yes, 0 = no) of whether or not person was tested for SARS-CoV-2 testing at syringe exchange visit, data collected from medical record
Outcome measures
| Measure |
Connect2Test Intervention + Contingency Management
n=177 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
Contingency Management Alone
n=172 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
|---|---|---|
|
SARS-CoV-2 Testing
Was tested
|
46 Participants
|
46 Participants
|
|
SARS-CoV-2 Testing
Was not tested
|
131 Participants
|
126 Participants
|
SECONDARY outcome
Timeframe: Immediate post intervention (i.e., same day)Yes/no indicator (coded 1 = yes, 0 = no) of whether or not person was vaccinated for COVID-19 at syringe exchange visit, data collected from vaccine records
Outcome measures
| Measure |
Connect2Test Intervention + Contingency Management
n=177 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
Contingency Management Alone
n=172 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
|---|---|---|
|
COVID-19 Vaccination
Was vaccinated
|
9 Participants
|
8 Participants
|
|
COVID-19 Vaccination
Was not vaccinated
|
168 Participants
|
164 Participants
|
SECONDARY outcome
Timeframe: Up to 9-months after interventionYes/no indicator (coded 1 = yes, 0 = no) of whether or not person was vaccinated for COVID-19 at syringe exchange visit, data collected from vaccine records
Outcome measures
| Measure |
Connect2Test Intervention + Contingency Management
n=177 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing plus a brief feedback-based motivational enhancement intervention.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
Contingency Management Alone
n=172 Participants
$10 financial incentive for vaccination and $10 financial incentive for testing.
Connect2Test: Brief motivational enhancement intervention to improve the likelihood of testing and vaccination among syringe exchange clients
|
|---|---|---|
|
COVID-19 Vaccination
Was vaccinated
|
19 Participants
|
5 Participants
|
|
COVID-19 Vaccination
Was not vaccinated
|
158 Participants
|
167 Participants
|
Adverse Events
Connect2Test Intervention + Contingency Management
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Contingency Management Alone
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place